These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5377616)

  • 1. 1-acetyl-2-picolinoylhydrazine (NSC-68626) in the treatment of advanced cancer.
    Olson KB; Horton J; Pratt KL; Paladine WJ; Cunningham T; Sullivan J; Hosley H; Treble DH
    Cancer Chemother Rep; 1969 Oct; 53(5):291-6. PubMed ID: 5377616
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of carcinoma of the lung with 1-acetyl-2-picolinoylhydrazine (NSC-68626).
    Wilson KS; Ricci JA; Grobmyer AJ
    Cancer Chemother Rep; 1970 Aug; 54(4):243-4. PubMed ID: 4946008
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 4. Procarbazine (NSC-77213) in the treatment of advanced bronchogenic carcinoma.
    Samuels ML; Leary WV; Howe CD
    Cancer Chemother Rep; 1969 Apr; 53(2):135-45. PubMed ID: 4895098
    [No Abstract]   [Full Text] [Related]  

  • 5. [Segidrin: a new-type antineoplastic agent].
    Filov VA
    Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in children.
    Sutow WW; Komp D; Vietti TJ; Pinkerton D
    Cancer Chemother Rep; 1975; 59(2 Pt 1):341-4. PubMed ID: 1097092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modalities and results of anticancer polychemotherapy in 73 cases of advanced broncho-pleuro-pulmonary cancer].
    Reboul AR; Lewest G
    Poumon Coeur; 1968; 24(1):117-23. PubMed ID: 5661797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent acquisitions in cancer chemotherapy].
    Amiel JL; Bernard J; Bessis M; Dreyfus B; Najean Y; Seligmann M; Péquignot H
    Presse Med (1893); 1966 Jun; 74(32):1683-6. PubMed ID: 5935822
    [No Abstract]   [Full Text] [Related]  

  • 9. [The results of a clinical study of the preparation hydrazine sulfate].
    Filov VA; Danova LA; Gershanovich ML; Ivin BA; Dement'eva NP; Breĭvis PV; Ragaĭshene VP; Kas'ianenko IV; Lisitsa AM; Mindlin SS
    Vopr Onkol; 1990; 36(6):721-6. PubMed ID: 2198698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Polychemotherapy of cancer].
    Jacquillat C; Weil M; Bernard J
    Poumon Coeur; 1968; 24(1):69-76. PubMed ID: 4968017
    [No Abstract]   [Full Text] [Related]  

  • 12. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
    Israel L; Bernard E
    Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].
    Kummer H; Bucher U
    Schweiz Med Wochenschr; 1965 Sep; 95(37):1233-40. PubMed ID: 5863643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy].
    Agati G
    Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968
    [No Abstract]   [Full Text] [Related]  

  • 15. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(10):1327-30. PubMed ID: 9614826
    [No Abstract]   [Full Text] [Related]  

  • 16. Three stakes in hydrazine sulfate's heart, but questionable cancer remedies, like vampires, always rise again.
    Herbert V
    J Clin Oncol; 1994 Jun; 12(6):1107-8. PubMed ID: 8201370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on the short-term effects of a synthetic antiblastic agent, a derivative of methylhydrazine, with or without radiotherapy].
    Massenti S; Perri G
    Minerva Radiol; 1967 Apr; 12(4):140-4. PubMed ID: 5613803
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
    Kingra GS; Comis R; Olson KB; Horton J
    Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antitumor polychemotherapy].
    Alberto P
    Poumon Coeur; 1968; 24(1):21-6. PubMed ID: 5652203
    [No Abstract]   [Full Text] [Related]  

  • 20. Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.
    Harrison SD; Plowman J; Dykes DJ; Waud WR; Griswold DP
    Cancer Res; 1991 Apr; 51(8):1979-83. PubMed ID: 2009516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.